Mammalian Target of Rapamycin Inhibition Halts the Progression of Proteinuria in a Rat Model of Reduced Renal Mass

scientific article published on 05 September 2007

Mammalian Target of Rapamycin Inhibition Halts the Progression of Proteinuria in a Rat Model of Reduced Renal Mass is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1681/ASN.2007010087
P698PubMed publication ID17804674

P50authorElisenda Banon-ManeusQ42418295
Jordi RoviraQ42418297
Mercè BrunetQ43119608
Fritz DiekmannQ43278879
María José Ramírez-BajoQ57962800
P2093author name stringJosep M Campistol
Alex Gutiérrez-Dalmau
Edgar M Arellano
Joaquim Carreras
P433issue10
P921main subjectsirolimusQ32089
P304page(s)2653-2660
P577publication date2007-09-05
P1433published inJournal of the American Society of NephrologyQ17123893
P1476titleMammalian target of rapamycin inhibition halts the progression of proteinuria in a rat model of reduced renal mass
P478volume18

Reverse relations

cites work (P2860)
Q85964497AKT2 is essential to maintain podocyte viability and function during chronic kidney disease
Q36514846Activation of the Renal PI3K/Akt/mTOR Signaling Pathway in a DOCA-Salt Model of Hypertension
Q28731390Delayed mTOR inhibition with low dose of everolimus reduces TGFβ expression, attenuates proteinuria and renal damage in the renal mass reduction model
Q41066466Differential effects of rapamycin in anti-GBM glomerulonephritis
Q43224209Effects of delayed rapamycin treatment on renal fibrosis and inflammation in experimental ischemia reperfusion injury
Q33815529In vivo analysis of gene expression in long-lived mice lacking the pregnancy-associated plasma protein A (PappA) gene
Q37435140Increased Phosphorylation of PI3K/Akt/mTOR in the Obstructed Kidney of Rats with Unilateral Ureteral Obstruction
Q38615411Inhibition of Mammalian Target of Rapamycin Complex 1 Attenuates Salt-Induced Hypertension and Kidney Injury in Dahl Salt-Sensitive Rats
Q41787297Is There a Role for Mammalian Target of Rapamycin Inhibition in Renal Failure due to Mesangioproliferative Nephrotic Syndrome?
Q46105800Late conversion to everolimus complicated with necrotizing glomerulonephritis in a renal allograft recipient: case report.
Q37836540Loss of tolerance to self after transplant
Q37052029Mammalian Target of Rapamycin Mediates Kidney Injury Molecule 1-Dependent Tubule Injury in a Surrogate Model.
Q33761197Mis-regulation of mammalian target of rapamycin (mTOR) complexes induced by albuminuria in proximal tubules
Q37218108Nonimmunosuppressive effects of mammalian target of rapamycin inhibitors
Q37360338Proteomic and phosphoproteomic analysis of renal cortex in a salt-load rat model of advanced kidney damage
Q34217419Rapamycin ameliorates kidney fibrosis by inhibiting the activation of mTOR signaling in interstitial macrophages and myofibroblasts
Q43016412Rapamycin induces growth retardation by disrupting angiogenesis in the growth plate
Q38914374Roles of mTOR complexes in the kidney: implications for renal disease and transplantation.
Q54117446Tofacitinib halts progression of graft dysfunction in a rat model of mixed cellular and humoral rejection.
Q37810461mTOR and rapamycin in the kidney: signaling and therapeutic implications beyond immunosuppression
Q37218125mToR inhibitors-induced proteinuria: mechanisms, significance, and management

Search more.